Supernus Pharmaceuticals   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Rockville MD United States (2005)

Organization Overview

First Clinical Trial
2008
NCT00626236
First Marketed Drug
2005
apomorphine (apokyn)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

MDD US | Supernus Pharmaceuticals | Supernus Pharmaceuticals, Inc. | SUPERNUS PHARMS